Interlace Medical Shareholders Sue Hologic, Inc.
Published: Nov 27, 2013
Shareholders of Interlace Medical, which Hologic acquired in 2011, sue the women's health company for additional payouts of almost $15 million. Hologic (NSDQ:HOLX) has already been through its fair share of legal action from its acquisition of Interlace Medical, which it acquired for $125 million in 2011. Bedford, Mass.-based Hologic lost a patent infringement lawsuit to rival Smith & Nephew (FTSE:SN, NYSE:SNN) last year over the MyoSure fibroid device it bought along with Interlace.
Help employers find you! Check out all the jobs and post your resume.